Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Felbamate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Felbamate 600mg tablets
0408010AAAAABAB
|
Felbamate | Felbamate | Central Nervous System | 17 |
|
Felbamate 600mg/5ml oral suspension
0408010AAAAACAC
|
Felbamate | Felbamate | Central Nervous System | 3 |
|
Taloxa 600mg tablets
0408010AABCAAAB
|
Taloxa | Felbamate | Central Nervous System | 1 |
|
Taloxa 600mg/5ml oral suspension
0408010AABCABAC
|
Taloxa | Felbamate | Central Nervous System | 1 |
|
Felbamate 400mg tablets
0408010AAAAAAAA
|
Felbamate | Felbamate | Central Nervous System | No data available |
|
Felbatol 400mg tablets
0408010AABBAAAA
|
Felbatol | Felbamate | Central Nervous System | No data available |
|
Felbatol 600mg tablets
0408010AABBABAB
|
Felbatol | Felbamate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.